Pharmaceutical company Pfizer reduced its net profit in 2018 by half to $11.153 billion, according to financial statements. Earnings per share fell to $1.87 against $3.52 for the earnings period last year. The company's revenue rose 2% to $53.65 billion. The last quarter of the year brought Pfizer a loss of $394 million, while last year the company made a profit of $12.274 billion. The loss per share was $0.07 against a profit of $2.02 a year earlier. Revenues for the quarter increased by 2% to $13.976 billion, although analysts had expected the figure to be slightly lower - $13.899 billion. In 2019, plans to receive $52-54 billion in revenue. Experts had expected that the figure would be $54.3 billion. According to forecasts by Pfizer, earnings per share would be $2.82-2.92. Analysts' own forecast - $3.04 per share. Pfizer is one of the leaders in the pharmaceutical industry. The company was founded in 1849 in the United States.
Pfizer outsources drug production to focus on experimental coronavirus vaccine27.03.2020
Chinese industrial firms report steepest decline in profits in a decade16.03.2020
Boaz Weinstein reports Saba funds gaining record profits amid plummeting market25.02.2020
S&P 500 drops to its lowest since 2018 over coronavirus fears